Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents

Environmental Health Perspectives

Volumn 106, Issue 8, 1998, Pages 437-445

  Hurley, Pamela M ^a   Hill, Richard N ^a   Whiting, Rick J ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

5' monodeiodinase activity; Induction of hepatic microsomal enzymes; Iodide pump; Mode of carcinogenic action; Pesticides; Thyroid follicular cell tumors; Thyroid hormone; Thyroid peroxidase activity; Thyroid stimulating hormone

Indexed keywords

(ETHYLHEXYL)NORBORNENEDICARBOXIMIDE; 2 IMIDAZOLIDINETHIONE; AMITROLE; BROMACIL; CARCINOGEN; CHLORBUTOL; CLOFENTEZINE; ETRIDIAZOLE; FENBUCONAZOLE; FIPRONIL; LIOTHYRONINE; MANCOZEB; PENDIMETHALIN; PESTICIDE; PRODIAMINE; PYRIMETHANIL; QUINTOZENE; TERBUTRYN; THIAZOPYR; THYROID PEROXIDASE; THYROTROPIN; THYROXINE; TRIADIMEFON; TRIFLURALIN; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENICITY; CELL GROWTH; ENZYME INHIBITION; HYPOPHYSIS THYROID SYSTEM; LIVER CANCER; LIVER METABOLISM; MUTAGENESIS; MUTAGENICITY; PRIORITY JOURNAL; THYROID CELL; THYROID FOLLICLE CELL; THYROID FOLLICULAR CARCINOMA;

ANIMALIA; RODENTIA;

EID: 0031677817     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106437     Document Type: Article

References (74)

1. Hill RN, Erdreich LS, Paynter OE, Roberts PA, Rosenthal SL, Wilkinson C. Thyroid follicular cell carcinogenesis. Fundam Appl Toxicol 12:629-697 (1989).
2. NRC. Health Effect of Exposure to Low Levels of Ionizing Radiation. BEIR V. Washington, DC:National Academy Press, 1990:281-298.
3. International conference sponsored by the International Atomic Energy Agency, the European Commission, and the World Health Organization. One Decade after Chernobyl. Summing Up the Consequences of the Accident, 8-12 April 1996, Vienna, Austria.
4. Hiasa Y, Kitahori Y, Kitamura M, Nishioka H, Yane K, Fukumoto M, Ohshima M, Nakaoka S, Nishii S. Relationships between serum thyroid stimulating hormone levels and development of thyroid tumors in rats treated with N-bis-(2-hydroxypropyl) nitrosamine. Carcinogenesis 12:873-877 (1991).
5. Hard GC. Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis. Environ Health Perspect 106:427-436 (1998).
6. Capen CC, Martin SL. The effects of xenobiotics on the structure and function of thyroid follicular and C-cells. Toxicol Pathol 17:266-293 (1989).
7. McClain RM. The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: implications for thyroid gland neoplasia. Toxicol Pathol 17:294-306 (1989).
8. McClain RM. Mechanistic considerations for the relevance of animal data on thyroid neoplasia to human risk assessment. Mutat Res 333:131-142 (1995).
9. Paynter OE, Burin GJ, Jaeger RB, Gregorio CA. Goitrogens and thyroid follicular cell neoplasia: evidence for a threshold process. Regul Toxicol Pharmacol 8:102-119 (1988).
10. Wynford-Thomas D, Williams ED, eds. Thyroid Tumours: Molecular Basis of Pathogenesis. New York:Churchill Livingston, 1989.
11. Hill RN, Crisp TM, Hurley PM, Rosenthal SL, Singh DV. Risk assessment of thyroid follicular cell tumors. Environ Health Perspect 106:000-000 (1998).
12. U.S. EPA. Assessment of Thyroid Follicular Cell Tumors. Risk Assessment Forum. EPA/630/R-97/002. Washington, DC:U.S. Environmental Protection Agency, 1997.
13. U.S. EPA. Guidelines for carcinogen risk assessment Fed Reg 51:33992-34003 (1986).
14. U.S. EPA. Proposed guidelines for carcinogen risk assessment. Fed Reg 61:17960-18011 (1996).
15. Alexander NM. Antithyroid action of 3-amino-1,2,4-triazole. J Biol Chem 234:147-150 (1959).
16. Arnold DL, Krewski DR, Junkins DB, McGuire PF, Moodie CA, Munco IC. Reversibility of ethylene thiourea-induced thyroid lesions. Toxicol Appl Pharmacol 67:264-273 (1983).
17. Cepen CC. Toxic responses of the endocrine system. In: Casarett and Doull's Toxicology: The Basic Science of Poisons (Klaassen CD, Amdur, MO, Doull J, eds). New York:McGraw-Hill, 1996;617-640.
18. Dalvi RR, Dalvi PS. Differences in the effects of piperine and piperonyl butoxide on hepatic drug-metabolizing enzyme system in rats. Drug Chem Toxicol 14:219-229 (1991).
19. Fregley MJ. Effect of aminotriazole on thyroid function in the rat. Toxicol Appl Pharmacol 13:271-286 (1968).
20. Freudenthal RI, Kerchner G, Persing R, Baron RL. Dietary subacute toxicity of ethylene thiourea in the laboratory rat. J Environ Pathol Toxicol 1:147-161 (1977).
21. Graham SL, Hansen WH. Effects of short term administration of ethylene thiourea upon thyroid function of the rat. Bull Environ Contam Toxicol 7:19-25 (1972).
22. Hotz KJ, Wilson AGE, Thake DC, Roloff MV, Capen CC, Kronenberg JM, Brewster DW. Mechanism of thiazopyr-induced effects on thyroid hormone homeostasis in male Sprague-Dawley rats. Toxicol Appl Pharmacol 142:133-142 (1997).
23. Krechniak J, Englot B, Wrzesniowska EH. Interaction of lindane and carbaryl on hepatic microsomal enzymes in rats. Bull Environ Contam Toxicol 52:927-934 (1994).
24. Moody DE, Narloch BA, Shull LR, Hammock BD. The effect of structurally divergent herbicides on mouse liver xenobiotic-metabolizing enzymes (P-450-dependent mono-oxygenases, epoxide hydrolases and glutathione S-transferases) and carnitine acetyltransferase. Toxicol Lett 59:175-185 (1991).
25. Naydenova Z, Urshev Z, Golovinsky E, Grancharov K. Influence of pesticides on UDP-glucuronyltransferase in rat liver microsomes. Pestic Sci 47:25-30 (1996).
26. O'Neil WM. Goitrogenic effects of ethylene thiourea on rat thyroid. Pastic Biochem Physiol 21:92-101 (1984).
27. Strum JM, Karnovsky MJ. Aminotriazole goiter. Fine structure and localization of thyroid peroxidase activity. Lab Invest 24:1-12 (1971).
28. Tsuda H. Studies on effects of 3-amino-1,2,4-triazole in rat thyroids. Nagoya Shiritsu Daigaku lgakkai Zasshi 26:87-94 (1975).
29. Tsuda H, Hirose M, Fukushima A, Takahashi M. Changes in the thyroid gland of rats given 3-amino-1,2,4-triazole. II. Changes following long term administration. Nippon Byori Gakku Kaishi 63:136-192 (1974).
30. Tsutsui T, Maizumi H, Barrett JC. Amitrole-induced cell transformation and gene mutations in Syrian hamster embryo cells in culture. Mutat Res 140:205-207 (1984).
31. Wilkinson CF, Murray M, Marcus CB. Interactions of methylenedioxyphenyl compounds with cytochrome P-450 and effects on microsomal oxidation. In: Reviews in Biochemical Toxicology (Hodgson D, Bend JR, Philpot RM, eds). New York:Elsevier, 1984;27-64.
32. Wynford-Thomas D, Stringer BMJ, Williams ED. Goitrogen-induced thyroid growth in the rat: a quantitative morphometric study. J Endocrinol 94:131-140 (1982).
33. Wynford-Thomas D, Stringer BMJ, Williams ED, Dissociation of growth and function in the thyroid during prolonged goitrogen administration. Acta Endrocrinol 101:210-216 (1982).
34. Wynford-Thomas D, Stringer BMJ, Williams ED, Desensitisation of rat thyroid to the growth-stimulating action of TSH during prolonged goitrogen administration. Acta Endocrinol 101:562-569 (1982).
35. 1 Mice (Feed Studies). TR No. 388. Research Triangle Park, NC:National Toxicology Program, 1992.
36. Contrera JF, Jacobs AC, DeGeorge JJ, Chen CH, Choudary JB, DeFelice AF, Fairweather WR, Farrelly JG, Fitzgerald GG, Goheer AM, et al. Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals. Regul Toxicol Pharmacol 25:130-145 (1997).
37. NTP. Numbers of Chemicals Associated with Site-specific Neoplasia. Research Triangle Park, NC:National Toxicology Program, http://ntp-server.niehs.nih.gov/ htdocs/Sites/PSite_Cnt.html [cited 20 March 1998].
38. Döhler KD, Wong CC, von zur Mühlen A. The rat as a model for the study of drug effects on thyroid function: consideration of methodological problems. Pharmacol Ther 5:305-318 (1979).
39. Parker SL, Tong T, Beiden S, Wingo PA. Cancer statistics, 1997. CA-Cancer J Clin 47:5-27 (1997).
40. McConnell EE. Thyroid follicular cell carcinogenesis: results from 343 2-year Carcinogenicity studies conducted by the NCI/NTP. Regul Toxicol Pharmacol 16:177-188 (1992).
41. Haseman JK, Lockhart A-M. Correlations between chemically related site-specific carcinogenic effects in long-term studies in rats and mice. Environ Health Perspect 101:50-54 (1993).
42. Davies TS, Monro A. Marketed human pharmaceuticals reported to be tumorigenic in rodents. J Am Coll Toxicol 14:90-107 (1995).
43. Ashby J, Kier L, Wilson AGE, Green T, Lefevre, PA, Tinwell H, Willis GA, Heydens WF, Clapp MJL. Evaluation of the potential Carcinogenicity and genetic toxicity to humans of the herbicide acetochlor. Hum Exp Toxicol 15:702-735 (1996).
44. Green WL. Mechanisms of action of antithyroid compounds. In: The Thyroid (Werner SC, Ingbar SH, eds), New York:Harper and Row, 1978;77-87.
45. Byrne JJ, Carbone JP, Hanson EA. Hypothyroidism and abnormalities in the kinetics of thyroid hormone metabolism in rats treated chronically with polychlorinated biphenyl and polybrominated biphenyl. Endocrinology 121:520-527 (1987).
46. Doerge DR, Niemczura WP. Suicide inactivation of lactoperoxidase by 3-amino-1,2,4-triazole. Chem Res Toxicol 2:100-103 (1989).
47. Doerge DR, Takazawa RS. Mechanism of thyroid peroxidase inhibition by ethylenethiourea. Chem Res Toxicol 3:98-101 (1990).
48. Kackar R, Srivastava MK, Raizada RB. Studies on rat thyroid after oral administration of mancozeb: morphological and biochemical evaluations. J Appl Toxicol 17:369-375 (1997).
49. Steinhoff D, Weber H, Mohr U, Boehme K. Evaluation of amitrole (aminotriazole) for potential Carcinogenicity in orally dosed rats, mice, and golden hamsters. Toxicol Appl Pharmacol 69:161-169 (1983).
50. IARC. Propylthouracil. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 7: Some Anti-Thyroid and Related Substances, Nitrofurans and Industrial Chemicals. Lyon: International Agency for Research on Cancer, 1974;67-76.
51. 1mice. Food Chem Toxicol 27:455-463 (1989).
52. Littlefield NA, Sheldon WG, Allen R, Gaylor DW. Chronic toxicity/carcinogenicity studies of sulphamethazine in Fischer 344/N rats: two generation exposure. Food Chem Toxicol 28:157-167 (1990).
53. Owen NV, Worth HM, Kiplinger GF. The effects of long-term ingestion of methimazole on the thyroids of rats. Food Cosmet Toxicol 11:649-653 (1973).
54. 1 Mice (Gavage Studies). TR 403. Research Triangle Park, NC:National Toxicology Program.
55. 1 Mice (Gavage Studies). TR 330. Research Triangle Park, NC:National Toxicology Program.
56. Wilson AG, Thake DC, Heydens WE, Brewster DW, Hotz KJ. Mode of action of thyroid tumor formation in the male Long-Evans rat administered high doses of alachlor. Fundam Appl Toxicol 33:16-23 (1996).
57. Bookstaff RC, Murphy VA, Skare JA, Minnema D, Sanzgiri U, Parkinson A. Effects of doxylamine succinate on thyroid hormone balance and enzyme induction in mice. Toxicol Appl Pharmacol 141:584-594 (1996).
58. Curran PG, DeGroot LJ. The effect of hepatic enzyme- inducing drugs on thyroid hormones and the thyroid gland. Endocr Rev 12:135-150 (1991).
59. Griffin RJ, Dudley CN, Cunningham ML. Biochemical effects of the mouse hepatocarcinogen oxazepam: similarities to phenobarbital. Fundam Appl Toxicol 29:147-154 (1996).
60. Semler DE, Chengelis CP, Radzialowski FM. The effects of chronic ingestion of spironolactone on serum thyrotropin and thyroid hormones in the male rat. Toxicol Appl Pharmacol 98:263-268 (1989).
61. Smith PF, Grossman SJ, Gerson RJ, Gordon LR, Deluca JG, Majka JA, Wang RW, Germershausen JI, MacDonald JS. Studies on the mechanism of simvastatin-induced thyroid hypertrophy and follicular cell adenoma in the rat. Toxicol Pathol 19:197-205 (1991).
62. Barter RA, Klaassen CD. UDP-glucuronosyl transferase inducers reduce thyroid hormone levels in rats by an extrathyroidal mechenism. Toxicol Appl Pharmacol 113:36-42 (1992).
63. Barter RA, Klaassen CD. Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDP-glucuronosyltransferase inducers in rats. Toxicol Appl Pharmacol 128:9-17 (1994).
64. 4metabolism and thyroid gland function in rats. Toxicol Appl Pharmacol 111:263-278 (1991).
65. Kohn MC, Sewall CH, Lucier GW, Portier CJ. A mechanistic model of effects of dioxin on thyroid hormones in the rat. Toxicol Appl Pharmacol 164:29-48 (1996).
66. Saito K, Kaneko H, Sato K, Yoshitake A, Yamada H. Hepatic UDP-glucuronyltransferase activity toward thyroid hormones in rats: induction and effects on serum thyroid hormone levels following treatment with various enzyme inducers. Toxicol Appl Pharmacol 111:99-106 (1991).
67. Balsam A, Sexton F, Forges M, Ingbar SH. Formation of diodotyrosine from thyroxine. Ether-link cleavage, an alternate pathway of thyroxine metabolism. J Clin Invest 72:1234-1245 (1983)
68. Cartier L-J, Williams IK, Holloszy J, Premachancra BN. Potentiation of thyroxine 5-deiodination by aminotriazole. Biochim Biophys Acta 843:68-72 (1985).
69. Scammell JG, Fregly MJ. The effect of 3-amino-1,2,4-triazole on hepatic and renal deiodination of L-thyroxine to 3,5,3′-triiodothyronine. Toxicol Appl Pharmacol 60:45-51 (1981).
70. Astwood EB, Bissell A, Hughes AM. Further studies on the chemical nature of compounds which inhibit the function of the thyroid gland. Endocrinology 37:56-481 (1945).
71. NCI. Bioassay of Trimethylthiourea for Possible Carcinogenicity. Technical Rept 129. Bethesda, MD: National Cancer Institute, 1979.
72. 1mice. J Toxicol Environ Health 18:325-337 (1986).
73. Gerber H, Huber G, Peter HJ, Kämpf J, Lemarchand-Beraud T, Fragu P, Stocker J. Transformation of normal thyroids into colloid goiters in rats and mice by diphenylthiohydantoin. Endocrinology 135:2688-2699 (1994).
74. Peer Review Panel. An Inquiry into the Mechanism of Carcinogenic Action cf FD&C Red No. 3 and Its Significance for Risk Assessment. A Report by the FD&C Red No. 3 Peer Review Panel. Washington, DC:Food and Drug Administration, 1987.